AKZO NOBEL SPONS.ADRS 1/3 (AKUP) — Working Capital to Net Assets Ratio
AKZO NOBEL SPONS.ADRS 1/3 (AKUP) has a Working Capital to Net Assets ratio of 75.7% as of June 2026. Working capital of €3.81 Billion (current assets of €8.12 Billion minus current liabilities of €4.31 Billion) is measured against net assets of €5.03 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See AKZO NOBEL SPONS.ADRS 1/3 (AKUP) liquidity interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
AKZO NOBEL SPONS.ADRS 1/3 Working Capital to Net Assets (2022–2025)
This chart shows how AKZO NOBEL SPONS.ADRS 1/3's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the ratio stands at 75.7%, reflecting working capital of €3.81 Billion against net assets of €5.03 Billion EUR. For the complete balance sheet picture, see AKZO NOBEL SPONS.ADRS 1/3 (AKUP) total assets.
Annual Working Capital to Net Assets for AKZO NOBEL SPONS.ADRS 1/3 (2022–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for AKZO NOBEL SPONS.ADRS 1/3 from 2022 to 2025, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check AKZO NOBEL SPONS.ADRS 1/3 liquidity resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 38.4% | €1.85 Billion | €4.82 Billion | €6.06 Billion | €4.21 Billion | ▲ +15.5 pp |
| 2024 | 23.0% | €1.11 Billion | €4.82 Billion | €5.84 Billion | €4.73 Billion | ▲ +15.5 pp |
| 2023 | 7.4% | €338.00 Million | €4.55 Billion | €6.04 Billion | €5.71 Billion | ▼ -3.5 pp |
| 2022 | 10.9% | €498.00 Million | €4.55 Billion | €6.24 Billion | €5.75 Billion | — |